Biontech

Latest Stories

In this photo provided by Cincinnati Children’s Hospital Medical Center, clinical research coordinator Tammy Lewis-McCauley administers an injection to Katelyn Evans, a trial participant, as part of the hospital’s clinical trial of Pfizer's COVID-19 vaccine at Cincinnati Children’s Hospital Medical Center on Wednesday, Oct. 14, 2020. (Cincinnati Children’s Hospital Medical Center via AP)

Pfizer: Early look shows COVID-19 vaccine is 90% effective

By Tom Howell Jr. - The Washington Times

In this photo provided by Cincinnati Children’s Hospital Medical Center, clinical research coordinator Tammy Lewis-McCauley administers an injection to Katelyn Evans, a trial participant, as part of the hospital’s clinical trial of Pfizer's COVID-19 vaccine at Cincinnati Children’s Hospital Medical Center on Wednesday, Oct. 14, 2020. (Cincinnati Children’s Hospital Medical Center via AP)

Pfizer says early data signals COVID-19 vaccine is effective

By Linda A. Johnson and Lauran Neergaard - Associated Press

A man walks past an electronic stock board showing Japan's Nikkei 225 index at a securities firm in Tokyo Monday, Nov. 9, 2020. Asian shares rose Monday on relief the U.S. presidential election results were finally decided, with Joe Biden the president-elect. (AP Photo/Eugene Hoshiko)

Asian stocks rise for 2nd day on coronavirus vaccine hopes

By JOE McDONALD - Associated Press

FILE - In this Feb. 26, 2019 file photo, Albert Bourla, chief executive officer of Pfizer, prepares to testify before the Senate Finance Committee hearing on drug prices, on Capitol Hill in Washington. Pfizer Inc.'s CEO says it can't seek emergency authorization of its COVID-19 vaccine before the third week of November — and that's if everything goes well. The announcement on Friday, Oct. 16, 2020, by Bourla reflects estimates from leading scientists that its unlikely data would start to emerge until November or December showing any of the leading vaccine candidates work. (AP Photo/Pablo Martinez Monsivais, File)

Pfizer: Mid-November earliest it can seek virus vaccine OK

Associated Press

German Health Minister Jens Spahn, left, and Science and Education Minister Anja Karliczek, right, arrive for a news conference about a german program to support the develop a COVID-19 vaccine in Berlin, Germany, Tuesday, Sept. 15, 2020.(AP Photo/Markus Schreiber, Pool)

Germany boosts own vaccine makers in race for COVID-19 jab

Associated Press

Scientific Games; Nvidia rise; Marathon Oil, Hologic fall

Associated Press

Navajo Nation will participate in COVID-19 vaccine trials

Associated Press

In this Jan. 24, 2018, file photo, Albert Bourla, of Pfizer, attends the 48th annual meeting of the World Economic Forum, WEF, in Davos, Switzerland. (Gian Ehrenzeller/Keystone via AP, File)

Pfizer CEO:Albert Bourla: ‘Best guess’ is we’ll know efficacy of vaccine by end of October

By David Sherfinski - The Washington Times

A man stands near an electronic stock board showing Japan's Nikkei 225 index at a securities firm as a car passes by in Tokyo Thursday, Aug. 20, 2020. Asian shares slipped Thursday after sobriety set in on Wall Street, and the U.S. Federal Reserve minutes laid out challenges for the economy amid the coronavirus pandemic. (AP Photo/Eugene Hoshiko)

Asian shares track Wall Street gains amid vaccine hopes

By YURI KAGEYAMA - Associated Press

An inmate models the protective gear inmates manufacture as fellow inmate Luis Huaman makes face shields at a workshop in the Lurigancho prison, on the outskirts of Lima, Peru, Wednesday, Aug. 19, 2020. Health authorities and inmates look to implement protocols to curb the spread of COVID-19 at the overcrowded prison. (AP Photo/Martin Mejia)

The Latest: Virus spike in S Korea capital may be spreading

By The Associated Press - Associated Press

Connecticut Gov. Ned Lamont speaks at a press conference at Pfizer Groton on the companies research to develop a vaccine for COVID-19, Wednesday, July 22, 2020, in Groton, Conn. The federal government has agreed to pay nearly $2 billion for 100 million doses of a potential COVID-19 vaccine being developed by the U.S. drugmaker and its German partner BioNTech. (AP Photo/Stew Milne)

Pandemic hurts sales, profit for Pfizer amid restructuring

By LINDA A. JOHNSON - Associated Press

A woman wearing a face mask stands beneath a bank's electronic board showing the Hong Kong share index at Hong Kong Stock Exchange in Hong Kong Tuesday, July 28, 2020. Shares advanced in Asia on Tuesday after U.S. stocks resumed their upward march on Wall Street, while the price of gold pushed to nearly $1,970 per ounce. (AP Photo/Vincent Yu)

Asian shares mixed amid dismal earnings, Wall Street slump

By YURI KAGEYAMA - Associated Press

FILE - In this May 4, 2020 photo provided by the University of Maryland School of Medicine, the first patient enrolled in Pfizer's COVID-19 coronavirus vaccine clinical trial at the University of Maryland School of Medicine in Baltimore, receives an injection. The first of four experimental COVID-19 vaccines being tested by Pfizer and its German partner BioNTech showed encouraging results in very early testing of 45 people, the companies said Wednesday, July 1, 2020. (University of Maryland School of Medicine via AP)

Feds agree to buy 100 M doses of potential Pfizer vaccine

By The Associated Press - Associated Press

President Donald Trump speaks during a news conference at the White House, Wednesday, July 22, 2020, in Washington. (AP Photo/Evan Vucci)

Pfizer coronavirus vaccine deal touted by Trump

By Tom Howell Jr. - The Washington Times

Best Buy, Silgan rise; Snap, FirstEnergy fall

Associated Press

John Burkhardt, left, senior vice president of drug safety R&amp;D and head of the Pfizer Groton site speaks at a press conference at Pfizer Groton on the companies research to develop a vaccine for COVID-19, as Connecticut Gov. Ned Lamont stands by to answer questions Wednesday, July 22, 2020, in Groton, Conn. The federal government has agreed to pay nearly $2 billion for 100 million doses of a potential COVID-19 vaccine being developed by the U.S. drugmaker and its German partner BioNTech. (AP Photo/Stew Milne)

Pfizer’s CT scientists playing key role in vaccine effort

By SUSAN HAIGH - Associated Press

In this handout photo released by the University of Oxford a doctor takes blood samples for use in a coronavirus vaccine trial in Oxford, England, Thursday June 25, 2020. Scientists at Oxford University say their experimental coronavirus vaccine has been shown in an early trial to prompt a protective immune response in hundreds of people who got the shot. In research published Monday July 20, 2020 in the journal Lancet, scientists said that they found their experimental COVID-19 vaccine produced a dual immune response in people aged 18 to 55. British researchers first began testing the vaccine in April in about 1,000 people, half of whom got the experimental vaccine. (John Cairns, University of Oxford via AP)

UK coronavirus vaccine prompts immune response in early test

By MARIA CHENG - Associated Press

In this March 16, 2020, file photo, a patient receives a shot in the first-stage safety study clinical trial of a potential vaccine for COVID-19 at the Kaiser Permanente Washington Health Research Institute in Seattle. As the race for a vaccine against the new coronavirus intensifies, many rich countries are rushing to the front of the line by placing advance orders for the inevitably limited supply to guarantee their citizens are immunized first. (AP Photo/Ted S. Warren, File)

Pfizer, BioNTech win FDA fast-track approval for two coronavirus vaccine candidates

By David Sherfinski - The Washington Times

A chain-link fence lock is seen on a gate at a closed Ranchito Elementary School in the San Fernando Valley section of Los Angeles on Monday, July 13, 2020. Amid spiking coronavirus cases, Los Angeles Unified School District campuses will remain closed when classes resume in August, Superintendent Austin Beutner said Monday. (AP Photo/Richard Vogel)

Pfizer coronavirus vaccine fast-tracked by FDA

By David Sherfinski and Tom Howell Jr. - The Washington Times

In this March 16, 2020, file photo, a patient receives a shot in the first-stage safety study clinical trial of a potential vaccine for COVID-19, the disease caused by the new coronavirus, at the Kaiser Permanente Washington Health Research Institute in Seattle. A Maryland man who received a vaccine in Baltimore earlier this year believes he may have been successfully vaccinated as part of a clinical trial. (AP Photo/Ted S. Warren, File)

Maryland man thinks he is one of the first people to be vaccinated against coronavirus

By Shen Wu Tan - The Washington Times